Supported by

Tricuspid / Pulmonary valve

Latest tricuspid content in interventional cardiology - research, practice, and education

Endovascular treatments for complications of the tricuspid or pulmonary valve, such as the treatment for tricuspid regurgitation (TR), are at an early stage of clinical development with many novel devices being introduced each year. This topic explores the different parameters of this emerging field with information on the latest research, emerging tools, devices and techniques, vascular access; the role of adjunctive pharmacotherapy; imaging techniques such as echocardiography as well as understanding bleeding risks or patient selection. Find out more…

Filtered By
Tricuspid / Pulmonary valve

492 results

A comprehensive portfolio to treat tricuspid regurgitation

Join this discussion which was recorded in the PCR Live studio at PCR London Valves 2022, where Volker Rudolph and Azeem Latib, hosted by Philipp Lurz, talk about some new data and late trials in the field of transcatheter tricuspid valve therapies.

View more videos and course...

A comprehensive portfolio to treat tricuspid regurgitation

PCR London Valves 2022 - summaries of late-breaking science, trials and innovations

02 Dec 2022

Jonathan Curio provides a brief overview of the new data presented at PCR London Valves 2022 in the field of Tricuspid, TAVI and Mitral valves by providing summarised key take-aways!

Jonathan Curio

Author

Jonathan Curio
PCR London Valves 2022 - summaries of late-breaking science, trials and innovations

Tricuspid valve intervention - Get it right!

29 Nov 2022 – From PCR London Valves 2022

Watch this session if you want to learn tips and tricks that influence procedural strategy through a real-life case as well as anatomical factors that contribute to tricuspid valve complexity and choice of treatment, followed by the latest clinical data.

Tricuspid valve intervention

Surgical and transcatheter tricuspid intervention: state of the art - LIVE case

29 Nov 2022 – From PCR London Valves 2022

In this PCR London Valves 2022 session, follow 3 stunning case treatments:

  • Part 1: Triscupid TEER (Live)
    A 78-year-old male with a history of CABG (2015), PM-CRT (2015) and atrial fibrillation, presents a severe TR with an LVEF of 40%, preserved RV function and moderate pulmonary hypertension.
    They performed...
Surgical and transcatheter tricuspid intervention: state of the art

Imaging for tricuspid valve interventions

29 Nov 2022 – From PCR London Valves 2022

Among the abstracts proposed in this PCR LV 2022 session, discover echocardiographic predictors of effective edge-to-edge repair in TR, TR in patients with continuous right ventricular pacing, TR and severe left-sided valvular heart disease, and much more!

Imaging for tricuspid valve interventions

Treatment of multi-valve disease

29 Nov 2022 – From PCR London Valves 2022

Get a look at these presentations to learn more about the basic haemodynamic interactions between different valve lesions, the existing surgical standards (and evolving transcatheter standards) for the treatment of multi-valve disease, and to discover a selection of cases that demonstrate the importance of clear indications and appropriate timing...

Treatment of multi-valve disease

Transcatheter tricuspid valve intervention is booming: where are we now? and where are we going?

29 Nov 2022 – From PCR London Valves 2022

Watch these presentations to better understand what's happening in the field of tricuspid valve intervention and to appreciate the characteristics of current and newly emerging transcatheter devices.

Transcatheter tricuspid valve intervention is booming: where are we now? and where are we going?

Transcatheter tricuspid interventions: emerging evidence

29 Nov 2022 – From PCR London Valves 2022

Get insights into the latest studies regarding transcatheter tricuspid interventions with this selection of presentations on TriCLASP, bRIGHT, PASTE, EVALUATE, and more!

Transcatheter tricuspid interventions: emerging evidence

Rapid-fire abstracts: Session 10

29 Nov 2022 – From PCR London Valves 2022

Discover a selection of abstracts presented during PCR LV 2022: trends in utilisation of percutaneous tricuspid valve vegetation debulking in endocarditis 2017-19, association of TRI-SCORE with clinical outcomes after transcatheter tricuspid valve repair, transcatheter edge-to-edge repair vs. percutaneous annuloplasty for tricuspid regurgitation, and more!

Rapid-fire abstracts: Session 10

Rapid-fire abstracts: Session 11

29 Nov 2022 – From PCR London Valves 2022

Discover a selection of abstracts presented during PCR LV 2022: the impact of cerebral embolic protection devices on acute ischaemic stroke complicating TAVI, TTVR clinical results prediction based on surgical risk scores, effects of tricuspid transcatheter edge-to-edge repair on tricuspid annular diameter, and much more!

Rapid-fire abstracts: Session 11